Pharma Focus Asia

Berkshire Sterile Plans to Expand Lyophilisation Capacity in USA


Berkshire Sterile Manufacturing plans to add an additional lyophiliser to their infrastructure in USA.


The lyophilisation capacity doubles from 35,000 10R vials to 70,000 10R vials, and aims to address the critical need for its clients and ensure seamless accommodation of their requirements.

The new lyophiliser will be leveraging the resources from the infrastructure that was added in 2021, which indicates a strategic approach to optimising their existing capabilities.

Furthermore, by incorporating the same automated loading and unloading systems as their current lyophiliser, aims to build on lessons learnt from their existing operations, thereby streamlining their processes and ensuring efficiency.

It is anticipated that the lyophilisation of GMP (Good Manufacturing Practise) will be adding newly lyophiliser by the fourth quarter of 2025.


Name  Berkshire Sterile Manufacturing
Type    New Construction
Year     2025

Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACertara - Adopting the Power of AI to Drug Development ProjectsROUQETTE - Pharma Virtual LabDUPHAT 2024Thermo Fisher Scientific - Rapid Mycoplasma TestingAsia Healthcare Week 20247th Annual Pharma Project & Portfolio Management 2024CHEMICAL INDONESIA 2024INALAB 2024The Drug Safety Symposium 2024Medlab Middle East 2024ISPE Singapore Affiliate Conference & Exhibition 2024